Philips | PHIA - Cash And Equivalent


Philips reported EUR2.75B in Cash and Equivalent for its fiscal quarter ending in September of 2026.





Cash And Equivalent Change Date
ABB USD 3.81B 57M Sep/2026
Abbott USD 4.05B 1.05B Sep/2026
Aena EUR 1.39B 1.56B Jun/2026
Alcon AG USD 1.36B 223M Jun/2026
ASM International NV EUR 1.34B 158.6M Sep/2026
ASML Holding EUR 8.03B 1.36B Sep/2026
AstraZeneca USD 4.89B 2.67B Jun/2026
Bayer EUR 4.29B 1.44B Jun/2026
Boston Scientific USD 609M 70M Sep/2026
Demant DKK 1.5B 166M Jun/2026
EDAP TMS EUR 15.01M 14.82M Mar/2026
Edwards Lifesciences USD 3.11B 210.8M Sep/2026
Essilor EUR 1.93B 1.61B Jun/2026
Fresenius EUR 1.28B 780M Jun/2026
Fresenius Medical Care EUR 1.1B 37.86M Sep/2026
Geberit CHF 403.6M 4.1M Mar/2025
Getinge SEK 2.05B 909M Jun/2026
GN Store Nord DKK 685M 121M Sep/2026
GRIFOLS EUR 486M 27M Sep/2026
HeidelbergCement EUR 2.54B 1.21B Dec/2025
Intuitive Surgical USD 6.8B 1.83B Sep/2026
Koninklijke Philips EUR 1.79B 803M Jun/2026
Legrand EUR 1.96B 23.7M Jun/2026
Lonza CHF 719M 188M Dec/2025
Medtronic USD 1.69B 258M Jun/2026
Merck EUR 1.96B 788M Jun/2026
Philips EUR 2.75B 962M Sep/2026
Sanofi EUR 6.35B 806M Jun/2026
SAP EUR 9.36B 1.15B Sep/2026
Schneider Electric EUR 4.63B 621M Dec/2025
Trinity Biotech USD 5.14M 3.8M Dec/2025